JPWO2020060916A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020060916A5
JPWO2020060916A5 JP2021515027A JP2021515027A JPWO2020060916A5 JP WO2020060916 A5 JPWO2020060916 A5 JP WO2020060916A5 JP 2021515027 A JP2021515027 A JP 2021515027A JP 2021515027 A JP2021515027 A JP 2021515027A JP WO2020060916 A5 JPWO2020060916 A5 JP WO2020060916A5
Authority
JP
Japan
Prior art keywords
independently
alkyl
cycloalkyl
haloalkyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515027A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500469A5 (https=
JP7429224B2 (ja
JP2022500469A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051275 external-priority patent/WO2020060916A1/en
Publication of JP2022500469A publication Critical patent/JP2022500469A/ja
Publication of JP2022500469A5 publication Critical patent/JP2022500469A5/ja
Publication of JPWO2020060916A5 publication Critical patent/JPWO2020060916A5/ja
Application granted granted Critical
Publication of JP7429224B2 publication Critical patent/JP7429224B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515027A 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロヘプチル酸 Active JP7429224B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862732595P 2018-09-18 2018-09-18
US62/732,595 2018-09-18
PCT/US2019/051275 WO2020060916A1 (en) 2018-09-18 2019-09-16 Cycloheptyl acids as lpa antagonists

Publications (4)

Publication Number Publication Date
JP2022500469A JP2022500469A (ja) 2022-01-04
JP2022500469A5 JP2022500469A5 (https=) 2023-11-08
JPWO2020060916A5 true JPWO2020060916A5 (https=) 2023-11-08
JP7429224B2 JP7429224B2 (ja) 2024-02-07

Family

ID=68073224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515027A Active JP7429224B2 (ja) 2018-09-18 2019-09-16 Lpaアンタゴニストとしてのシクロヘプチル酸

Country Status (7)

Country Link
US (1) US20220041572A1 (https=)
EP (1) EP3852747B1 (https=)
JP (1) JP7429224B2 (https=)
KR (1) KR102800284B1 (https=)
CN (1) CN112702998A (https=)
ES (1) ES2948793T3 (https=)
WO (1) WO2020060916A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102788997B1 (ko) 2018-09-18 2025-03-28 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 옥사비시클로 산
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
AU2020384883B2 (en) 2019-11-15 2023-11-16 Gilead Sciences, Inc. Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof
TWI843503B (zh) 2020-06-03 2024-05-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
CN115867556B (zh) 2020-06-03 2025-05-06 吉利德科学公司 Lpa受体拮抗剂及其用途
TWI853704B (zh) 2021-05-11 2024-08-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
KR20240007233A (ko) * 2021-05-13 2024-01-16 길리애드 사이언시즈, 인코포레이티드 Lpa 수용체 길항제 및 이의 용도
WO2023107938A1 (en) 2021-12-08 2023-06-15 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
AR128613A1 (es) 2022-02-25 2024-05-29 Lhotse Bio Inc Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa
CN121866249A (zh) 2023-09-08 2026-04-14 海思科医药集团股份有限公司 一种lpar1拮抗剂及其用途
WO2026061483A1 (zh) * 2024-09-19 2026-03-26 西藏海思科制药有限公司 一种lpar1拮抗剂及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062389A1 (en) 2001-02-08 2002-08-15 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
TW201120016A (en) * 2009-12-08 2011-06-16 Abbott Lab Novel oxadiazole compounds
EP2694472B1 (en) 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
UA109868C2 (ru) 2012-06-20 2015-10-12 Ф. Хоффманн-Ля Рош Аг Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
AR108838A1 (es) 2016-06-21 2018-10-03 Bristol Myers Squibb Co Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
KR102788997B1 (ko) 2018-09-18 2025-03-28 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 옥사비시클로 산
ES2946657T3 (es) 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA

Similar Documents

Publication Publication Date Title
JP2021508686A5 (https=)
JPWO2020060915A5 (https=)
JP2021507895A5 (https=)
JP2021507900A5 (https=)
HRP20211918T1 (hr) Triazol n-vezane karbamoil cikloheksil kiseline kao lpa antagonisti
JP2021507896A5 (https=)
JP2021506878A5 (https=)
JPWO2019126086A5 (https=)
JPWO2019126099A5 (https=)
JPWO2019126085A5 (https=)
JPWO2020060916A5 (https=)
JP2020528889A5 (https=)
JP2020537657A5 (https=)
JP2020183410A5 (https=)
JP2019520396A5 (https=)
JP2019530669A5 (https=)
JP2019094345A5 (https=)
HRP20200586T1 (hr) Karbamoiloksimetil triazol cikloheksilne kiseline kao antagonisti lpa
JPWO2020060914A5 (https=)
JPWO2019212991A5 (https=)
JP2020507589A5 (https=)
JPWO2022040600A5 (https=)
RU2012151012A (ru) Циклопропиловые дикарбоксамиды и аналоги, обладающие противораковым и антипролиферативным действием
JPWO2020033828A5 (https=)
JP2009524691A5 (https=)